Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia

(2013) Noa Tejman-Yarden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictive methods in drug repurposing: gold mine or just a bigger haystack?

(2012) David Cavalla   DRUG DISCOVERY TODAY

The biological activity of auranofin: implications for novel treatment of diseases

(2012) J. M. Madeira et al.   INFLAMMOPHARMACOLOGY

Inhibition of Selenium Metabolism in the Oral Pathogen Treponema denticola

(2009) S. Jackson-Rosario et al.   JOURNAL OF BACTERIOLOGY

Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adduct

(2009) Sarah Jackson-Rosario et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Targeting selenium metabolism and selenoproteins: Novel avenues for drug discovery

(2009) Sarah Elizabeth Jackson-Rosario et al.   Metallomics

Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages

(2008) Shinha Han et al.   ARCHIVES OF PHARMACAL RESEARCH

New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro : Mechanistic and pharmacological implications

(2008) Anna Rosa Sannella et al.   FEBS LETTERS